☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Portfolio
Qiagen's NeuMoDx Multiplex Test Receives the US FDA's EUA and Expands its COVID-19 Portfolio
March 29, 2021
Novartis In-Licenses BieGene's Tislelizumab to Expand its Oncology Portfolio
January 12, 2021
Roche Highlights its Bispecific Antibody Portfolio Across a Range of Blood Cancers at ASH 2020
December 9, 2020
UCB Acquires Handl Therapeutics to Augment its Gene Therapy Portfolio
November 13, 2020
BMS to Acquire Forbius for its AVID200 to Expand its Footprints in Oncology and Fibrosis
August 24, 2020
Olympus to Acquire Arc Medical Design for Expanding its Product Portfolio
August 11, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.